Infrared Thermography for the Diagnosis of Musculoskeletal Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04097249|
Recruitment Status : Completed
First Posted : September 20, 2019
Last Update Posted : September 20, 2019
|Condition or disease|
|Healthy Pain Temperature Change, Body|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||20 participants|
|Target Follow-Up Duration:||2 Days|
|Official Title:||The Contribution and Validity of Infrared Thermography in the Diagnosis of Musculoskeletal Pain|
|Actual Study Start Date :||October 1, 2015|
|Actual Primary Completion Date :||April 29, 2016|
|Actual Study Completion Date :||April 30, 2016|
Participants free from any pain specific to the upper limb, chronic pain or other disease.
- Changes in temperature of pixels on the upper extremity: infrared thermography [ Time Frame: Day-1 (baseline assessment, pre exercise before painful stimulus), Day-1 (baseline assessment, pre exercise after painful stimulus), Day-2 (24 hours post-exercise before painful stimulus), Day-2 (24 hours post-exercise after painful stimulus) ]A thermography image of the upper extremity of the body will be taken on both days of assessment before and after applying a painful stimulus. Changes in colour pixels will be analysed to determine temperature changes.
- Changes in Pressure Pain Thresholds: pressure algometry [ Time Frame: Day-1 (baseline assessment, pre exercise before painful stimulus), Day-2 (24 hours post-exercise before painful stimulus) ]Changes in pressure pain thresholds will be determined with pressure algometry over the infraspinatus muscle. Pressure Pain Threshold is defined as the exact time point where the pressure is first being perceived as painful.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04097249
|Study Director:||Pablo Herrero, PhD||Universidad San Jorge|